Possible negative search results for OLIVER FETZER
OLIVER FETZER News
Oliver Steffen Fetzer Ph.D., MBA: Executive Profile & Biography ...
Dr. Oliver Steffen Fetzer, Ph.D., MBA, has been the Chief Executive Officer at
Synthetic Genomics, Inc. since October 27, 2014. Dr. Fetzer has extensive
experience in successful clinical development, deal transactions and
biopharmaceuticals leadership over his more than 20 years in the industry. He.
Cerulean CEO: The IPO Environment is Very Encouraging | Fox ...
7 Jan 2013
Cerulean Pharma CEO Oliver Fetzer on the company's cancer drugs and the challenges for ...
ExxonMobil and Synthetic Genomics Algae ... - NYTimes Markets
6 Mar 2018 ... “We are excited to take this next significant step as we journey together toward a
renewable, scalable, and low-carbon biofuel,” said Oliver Fetzer , Ph.D., chief
executive officer at Synthetic Genomics. “The progress we are making in the lab
toward engineering highly efficient algae strains that convert ...
Arena Pharmaceuticals Inc (ARNA.O) People | Reuters.com
Oliver Fetzer. Dr. Oliver S. Fetzer, Ph.D., is an Independent Director of the
Company. Dr. Fetzer serves as the Chief Executive Officer of Synthetic Genomics,
Inc., a private synthetic biology company commercializing genomic technologies,
since October 2014. Prior to Synthetic Genomics, Dr. Fetzer was President and